Search:


Media Contact
Annette Ballou
Email
216.658.3999
Newsroom > News
print
Spinal implant developer AxioMed Spine Corp. has raised another $5 million in equity financing from existing and new investors, closing a $20 million Series D financing round, the company announced Tuesday.

The Garfield Heights company said last week that it had received CE Mark approval to begin selling its Freedom Cervical Disc in the European Union. The product is designed to replace discs in the upper portion of the spine.

Click here to read more from Crain's Cleveland Business.
Exit Companies

Since 2002, 37 Cleveland-area healthcare companies have had successful exits. 
» View More



Cleveland: Biomedical
Innovation Destination


 

» View / Download






Sign Up for BioEnterprise eNews

Add me to your emailing list: sign up




Cleveland Medical Mart & Convention Center



The world’s only convention facility created for the healthcare industry.
» View More
 
Copyright © 2013 BioEnterprise.  | Home | Disclaimer | Sitemap | Contact Us |  Content software by Rapid Marketplace BioEnterprise : 11000 Cedar Avenue, Cleveland, OH 44106 | 216.658.3999